Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC–Driven Cancer Progression

Abstract excerpt

Abstract The ability of the N-MYC transcription factor to drive cancer progression is well demonstrated in neuroblastoma, the most common extracranial pediatric solid tumor, where MYCN amplification heralds a poor prognosis, with only 11% of high-risk patients surviving past 5 years. However, decades of attempts of direct inhibition of N-MYC or its paralogues has led to the conclusion that this protein is...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Neuroblastoma Research and Treatments
• Share to Protein Degradation and Inhibitors
• Share to Virus-based gene therapy research